by The global Pharmaceutical Contract Manufacturing And Research Services market size is expected to be worth around US$ 376.8 billion by 2030, according to a new report by Vision Research Reports.
Pharmaceutical Contract Manufacturing And Research Services Market (By Service: Manufacturing, Research) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38316
Market Insight
| Report Coverage | Details |
| Market Size | US$ 376.8 billion by 2030 |
| Growth Rate | CAGR of 10.75% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Service |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Catalent; Pharmaceutical Product Development LLC; AbbVie; Baxter BioPharma Solutions; Patheon; Grifols International, S.A.; Dalton Pharma Services; Boehringer Ingelheim Biopharmaceuticals GmbH; Lonza AG |
Report Highlights
The manufacturing service held the largest share of over 75.0% in 2020. These services are further segmented into API/bulk drugs manufacturing, advanced drug delivery formulations, packaging, and finished dose formulations. API dominated the market in 2020 as a consequence of the rising demand for High Potency Active Pharmaceutical Ingredients (HPAPI). Market entities are engaged in the development of large-scale manufacturing facilities on a pilot as well as commercial scale.
Finished dose formulations are anticipated to expand at the fastest CAGR over the forecast period. Amongst these, solid dosage forms accounted for the largest revenue share in 2020 due to the higher outsourcing done for the powdered formulations. It is expected to witness gradual expansion in the coming years as it represents a significant share of the outsourcing of finished dose formulations. Solid dose manufacturing and oral delivery of new drug candidates, fixed-dose combinations, controlled release dosage forms, and reformulation of existing drugs are some of the factors likely to accelerate the growth of contract manufacturing of solid dosage formulations.
Asia Pacific dominated the market with a revenue share of over 55.0% in 2020 and is projected to grow at a significant rate over the forecast period. This growth is supported by a rise in the number of companies outsourcing projects in the developing economies of this region. In recent years, countries such as Singapore, China, and India have been observed as major players in the pharmaceutical industry owing to their expanding manufacturing capabilities.
Key Players
- Catalent
- Pharmaceutical Product Development LLC
- AbbVie
- Baxter BioPharma Solutions
- Patheon
- Grifols International, S.A.
- Dalton Pharma Services
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Lonza AG
Market Segmentation
- Service Outlook
- Manufacturing
- API/Bulk Drugs
- Advanced Drug Delivery Formulations Packaging
- Packaging
- Finished Dose Formulations
- Solid Formulations
- Liquid Formulations
- Semi-solid Formulations
- Research
- Oncology
- Vaccines
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others
- Manufacturing
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Asia Pacific
- India
- China
- Latin America
- Brazil
- Mexico
- Colombia
- Argentina
- Chile
- Venezuela
- Middle East and Africa (MEA)
- South Africa
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38316
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Pharmaceutical Contract Manufacturing And Research Services Market, By Service
7.1. Pharmaceutical Contract Manufacturing And Research Services Market, by Service, 2020-2030
7.1.1. Manufacturing
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Research
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Pharmaceutical Contract Manufacturing And Research Services Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, by Service (2016-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Service (2016-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Service (2016-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Service (2016-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Service (2016-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Service (2016-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Service (2016-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Service (2016-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Service (2016-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Service (2016-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Service (2016-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Service (2016-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Service (2016-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Service (2016-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Service (2016-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Service (2016-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Service (2016-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Service (2016-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Service (2016-2030)
Chapter 9. Company Profiles
9.1. Company 1
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Company 2
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Company 3
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Company 4
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Company 5
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Company 6
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Company 7
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Company 8
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38316
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
